Growth factors and the kidney in diabetes mellitus.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Critical reviews in clinical laboratory sciences

• Publication date

  1998-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/10408369891234174PMID 9592624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Three-dimensional analysis of increased vasculature around the glomerular vascular pole in diabetic nephropathy

  2005cited by this paper
• Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus.

  1996cited by this paper
• High glucose-induced TGF-beta 1 regulates mesangial production of heparan sulfate proteoglycan.

  1996cited by this paper
• Effects of heparin on renal morphology and albuminuria in experimental diabetes.

  1996cited by this paper
• Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor

  1996cited by this paper
• Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor.

  1996cited by this paper
• The role of growth factors in the development of diabetic nephropathy

  1996cited by this paper
• Increased glomerular alpha 1 (IV) collagen expression and deposition in long-term diabetic rats is prevented by chronic glycosaminoglycan treatment.

  1996cited by this paper
• Nitric oxide: a modulator for the epidermal growth factor receptor expression in developing ovarian granulosa cells.

  1996cited by this paper
• Neutralization of TGF-β by Anti-TGF-β Antibody Attenuates Kidney Hypertrophy and the Enhanced Extracellular Matrix Gene Expression in STZ-Induced Diabetic Mice

  1996cited by this paper
• Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitus

  1996cited by this paper
• Increased activity of the insulin-like growth factor system in mesangial cells cultured in high glucose conditions. Relation to glucose-enhanced extracellular matrix production

  1996cited by this paper
• Analysis of insulin-like growth factors (IGF)-I, and -II, type II IGF receptor and IGF-binding protein-2 mRNA and peptide levels in normal and nephrectomized rat kidney.

  1995cited by this paper
• Transforming growth factor-beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis?

  1995cited by this paper
• Insulin-like growth factor-1 stimulates production of mesangial cell matrix components.

  1995cited by this paper
• Insulin-like growth factor I induces mesangial proliferation and increases mRNA and secretion of collagen.

  1995cited by this paper
• Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype.

  1995cited by this paper
• Insulin-like growth factor-1 stimulates production of mesangial cell matrix components.

  1995cited by this paper
• Localization of transforming growth factor-β and latent transforming growth factor-β binding protein in rat kidney

  1995cited by this paper
• Localization of transforming growth factor-beta and latent transforming growth factor-beta binding protein in rat kidney.

  1995cited by this paper
• Expression of growth-related protooncogenes during diabetic renal hypertrophy.

  1995cited by this paper
• Increased expression of heparin binding epidermal growth-factor-like growth factor mRNA in the kidney of streptozotocin-induced diabetic rats.

  1995cited by this paper
• Role for transforming growth factor beta in thromboxane-induced increases in mesangial cell fibronectin synthesis.

  1995cited by this paper
• Growth hormone and nutrition interact to regulate expressions of kidney IGF-I and IGFBP mRNAs.

  1995cited by this paper
• Cellular events in the evolution of experimental diabetic nephropathy.

  1995cited by this paper
• Overexpression of transforming growth factor-beta 1 mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice.

  1995cited by this paper
• Erythrocyte sodium-lithium countertransport: another link between essential hypertension and diabetes.

  1994cited by this paper
• High glucose and hyperosmolality stimulate hepatocyte growth factor secretion from cultured human mesangial cells

  1994cited by this paper
• Tissue-specific regulation of the growth hormone receptor gene in streptozocin-induced diabetes in the rat.

  1994cited by this paper
• Regional expression of hepatocyte growth factor/c-met in experimental renal hypertrophy and hyperplasia.

  1994cited by this paper
• Heparan sulfate proteoglycans in the human sclerosing and scarring kidney. Changes in heparan sulfate moiety.

  1994cited by this paper
• The emerging role of transforming growth factor-beta in kidney diseases.

  1994cited by this paper
• Activation of Protein Kinase C in Glomerular Cells in Diabetes: Mechanisms and Potential Links to the Pathogenesis of Diabetic Glomerulopathy

  1994cited by this paper
• Experimental diabetic renal growth: role of growth hormone and insulin-like growth factor-I.

  1994cited by this paper
• Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy.

  1994cited by this paper
• Intraglomerular expression of transforming growth factor‐beta 1 (TGF‐β1) mRNA in patients with glomerulonephritis: quantitative analysis by competitive polymerase chain reaction

  1994cited by this paper
• Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.

  1994cited by this paper
• Effects of growth hormone on rat renal epidermal growth factor expression.

  1994cited by this paper
• Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse.

  1994cited by this paper
• Induction of heparin-binding epidermal growth factor-like growth factor mRNA by protein kinase C activators.

  1994cited by this paper
• Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes.

  1994cited by this paper
• The contribution of mesangial cell collagen synthesis to the pathogenesis of diabetic nephropathy.

  1994cited by this paper
• Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy.

  1994cited by this paper
• Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta.

  1994cited by this paper
• Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease.

  1994cited by this paper
• Differential accumulation of insulin-like growth factor-I in kidneys of pre- and postpubertal streptozotocin-diabetic rats.

  1994cited by this paper
• Renal TGF-beta regulation in spontaneously diabetic NOD mice with correlations in mesangial cells.

  1994cited by this paper
• Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.

  1994cited by this paper
• Expression of transforming growth factor-β1 during diabetic renal hypertrophy

  1994cited by this paper
• Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta.

  1993cited by this paper
• Differential modulation of mitogenic and metabolic actions of insulin-like growth factor I in rat glomerular mesangial cells in high glucose culture

  1993cited by this paper
• The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes

  1993cited by this paper
• The transforming growth factor-beta system and the kidney.

  1993cited by this paper
• Insulin-like growth factor I and the kidney.

  1993cited by this paper
• Insulin-like growth factor-I and experimental diabetic kidney disease.

  1993cited by this paper
• Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. Induction of mRNA levels and secretion of active mitogen.

  1993cited by this paper
• Insulin-like growth factor 1 and sodium—lithium countertransport in essential hypertension and in hypertensive left ventricular hypertrophy

  1993cited by this paper
• Mesangial cells from diabetic NOD mice constitutively secrete increased amounts of insulin-like growth factor-I.

  1993cited by this paper
• Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.

  1993cited by this paper
• Growth factors in glomerulonephritis.

  1993cited by this paper
• The growth hormone insulin-like growth factor axis in kidney revisited

  1993cited by this paper
• Growth hormone and diabetes mellitus. A review of sixty-three years of medical research and a glimpse into the future?

  1993cited by this paper
• mRNA Expression of Growth Factors in Glomeruli From Diabetic Rats

  1993cited by this paper
• Effect of High Glucose on Type IV Collagen Production by Cultured Glomerular Epithelial, Endothelial, and Mesangial Cells

  1993cited by this paper
• Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats.

  1993cited by this paper
• Multi‐faceted regulation of cell differentiation by extracellular matrix

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Extracellular matrix and growth factors: an integrated interplay controlling tissue repair and progression to disease.

  1993cited by this paper
• Excretion of urinary epidermal growth factor in non-insulin dependent diabetes mellitus.

  1993cited by this paper
• Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis.

  1993cited by this paper
• Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo.

  1993cited by this paper
• Growth Hormone and Diabetes mellitus

  1993cited by this paper
• Trans-repressor activity of nuclear glycosaminoglycans on Fos and Jun/AP-1 oncoprotein-mediated transcription

  1992cited by this paper
• Growth factors in the pathogenesis of renovascular complications of diabetes mellitus.

  1992cited by this paper
• Increased distal nephron EGF content and altered distribution of peptide in compensatory renal hypertrophy.

  1992cited by this paper
• Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats.

  1992cited by this paper
• Expressions of receptor gene for hepatocyte growth factor in kidney after unilateral nephrectomy and renal injury.

  1992cited by this paper
• Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor

  1992cited by this paper
• Differential Tissue Regulation of Insulinlike Growth Factor Binding Proteins in Experimental Diabetes Mellitus in the Rat

  1992cited by this paper
• Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells.

  1992cited by this paper
• Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats

  1992cited by this paper
• Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor.

  1992cited by this paper
• The link between hyperglycaemia and diabetic nephropathy

  1992cited by this paper
• Antiproliferative effect of phorbol esters on MCF-7 human breast adenocarcinoma cells: relationship with enhanced expression of transforming growth-factor-beta 1.

  1992cited by this paper
• Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

  1992cited by this paper
• Changes in cyclic strain increase inositol trisphosphate and diacylglycerol in endothelial cells.

  1992cited by this paper
• Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material

  1992cited by this paper
• Renal growth hormone receptor gene expression: relationship to renal insulin-like growth factor system.

  1992cited by this paper
• Local infusion of IGF-I into the kidney of pituitary intact rats induces renal growth.

  1992cited by this paper
• Extracellular matrix-cell interactions: dynamic modulators of cell, tissue and organism structure and function.

  1992cited by this paper
• Kidney IGF-I and renal hypertrophy in GH-deficient diabetic dwarf rats.

  1992cited by this paper
• Hepatocyte growth factor is a paracrine factor for renal epithelial cells: stimulation of DNA synthesis and NA,K-ATPase activity.

  1992cited by this paper
• Changes in Blood Coagulation, Platelet Function, and Plasminogen-Plasmin System in Diabetes

  1992cited by this paper
• Elevated glucose decreases the content of a basement membrane associated heparan sulphate proteoglycan in proliferating cultured porcine mesangial cells

  1992cited by this paper
• Clustering of risk factors in hypertensive insulin-dependent diabetics with high sodium-lithium countertransport.

  1992cited by this paper
• Regulation of insulin-like growth factor I receptors in diabetic mesangial cells.

  1991cited by this paper
• Insulin-like growth factor I gene expression in isolated rat renal collecting duct is stimulated by epidermal growth factor.

  1991cited by this paper
• High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures.

  1991cited by this paper
• A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF

  1991cited by this paper
• Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy

  1991cited by this paper

• Progress in corneal wound healing.

  2015cites this paper
• Insulin-like growth factor (IGF)-I and IGF binding proteins axis in diabetes mellitus

  2015cites this paper
• Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes

  2014cites this paper
• Approaches to Prevention of Cardiovascular Complications and Events in Diabetes Mellitus

  2012cites this paper
• Interaction of monocytes with glomerular mesangial cell matrix in the pathogenesis of glomerular injury

  2011cites this paper
• Novel roles of the IGF-IGFBP axis in etiopathophysiology of diabetic nephropathy.

  2007influential citation
• Vascular Endothelial Cell Growth Factor Attenuates Actions of Transforming Growth Factor-β in Human Endothelial Cells*

  2004cites this paper
• Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy.

  2004cites this paper
• Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial.

  2002cites this paper
• The meaning of microalbuminuria in type 1 diabetes: The need for a new paradigm

  2001cites this paper
• Functional and structural changes in the kidney in the early stages of obesity.

  2001cites this paper
• Alterations of vitronectin and its receptor alpha(v) integrin in the rat renal glomerular wall during diabetes.

  2001cites this paper
• Low-molecular-weight heparin prevents high glucose- and phorbol ester-induced TGF-beta 1 gene activation.

  2001cites this paper
• Proteolysis of insulin-like growth factor-binding protein-3 is increased in urine from patients with diabetic nephropathy.

  2000cites this paper
• Glycosaminoglycan therapy prevents TGF-beta1 overexpression and pathologic changes in renal tissue of long-term diabetic rats.

  2000cites this paper
• For debate Glycosaminoglycan therapy for long-term diabetic complications?

  1998cites this paper
• Molecular biology of diabetic glomerulosclerosis.

  1998cites this paper